Prescription Information Modernization Act of 2025

HR 4132, the Prescription Information Modernization Act of 2025, allows drug manufacturers to provide FDA-approved prescribing information for prescription drugs exclusively through electronic means, while requiring them to offer paper copies at no additional cost upon request by prescribers or dispensers. The bill directly affects drug manufacturers, doctors, pharmacists, and other healthcare professionals who rely on prescribing information. Key provisions include mandating that manufacturers give prescribers/dispensers the choice to continue receiving paper copies or request them as needed, and requiring the HHS Secretary to issue implementing regulations within one year to support this transition. The law takes effect two years after enactment or when final regulations are issued, whichever comes first.